BioMarin Pharmaceutical, Inc. (BMRN)
53.83
+0.09
(+0.17%)
USD |
NASDAQ |
Dec 10, 12:51
BioMarin Pharmaceutical EPS Diluted (Quarterly): -0.1601 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Align Technology, Inc. | 0.7837 |
| Biogen, Inc. | 3.171 |
| Gilead Sciences, Inc. | 2.434 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.74M |
| Revenue (Quarterly) | 786.77M |
| Total Expenses (Quarterly) | 817.52M |
| Enterprise Value | 9.458B |
| Gross Profit Margin (Quarterly) | 81.58% |
| Profit Margin (Quarterly) | -3.91% |
| Earnings Yield | 4.96% |
| Operating Earnings Yield | 8.13% |
| Normalized Earnings Yield | 6.629 |